Inhibition of Pim-1 attenuates the proliferation and migration in nasopharyngeal carcinoma cells

Asian Pacific Journal of Tropical Medicine

Volumn 5, Issue 8, 2012, Pages 645-650

  Jie, Wei ^a   He, Qi Yi ^b   Luo, Bo Tao ^a   Zheng, Shao Jiang ^b   Kong, Yue Qiong ^b   Jiang, Han Guo ^a   Li, Ru Jia ^a   Guo, Jun Li ^b   Shen, Zhi Hua ^a  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b HAINAN MEDICAL UNIVERSITY   (China)

Author keywords

Cell migration; Cell proliferation; Nasopharyngeal carcinoma; Pim 1; Quercetagetin

Indexed keywords

LATENT MEMBRANE PROTEIN 1; PROTEIN KINASE PIM 1; PROTEIN SERINE THREONINE KINASE INHIBITOR; QUERCETAGETIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; COLONY FORMATION; CONTROLLED STUDY; ENZYME INHIBITION; NASOPHARYNX CARCINOMA; PLASMID; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

ANTINEOPLASTIC AGENTS; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CHROMONES; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; NASOPHARYNGEAL NEOPLASMS; PROTO-ONCOGENE PROTEINS C-PIM-1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR MARKERS, BIOLOGICAL; TUMOR STEM CELL ASSAY;

EID: 84864306058     PISSN: 19957645     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1995-7645(12)60132-1     Document Type: Article

References (34)

1. Cao SM, Simons MJ, Qian CN The prevalence and prevention of nasopharyngeal carcinoma in China. Chin J Cancer 2011, 30:114-119.
2. Cuypers HT, Selten G, Quint W, Zijlstra M, Maandag ER, Boelens W, et al. Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region. Cell 1984, 37:141-150.
3. Bachmann M, Moroy T The serine/threonine kinase Pim-1. Int J Biochem Cell Biol 2005, 37:726-730.
4. Allen JD, Berns A Complementation tagging of cooperating oncogenes in knockout mice. Semin Cancer Biol 1996, 7:299-306.
5. Jie W, Wang X, Zhang Y, Guo J, Kuang D, Zhu P, et al. SDF-1alpha/CXCR4 axis is involved in glucose-potentiated proliferation and chemotaxis in rat vascular smooth muscle cells. Int J Exp Pathol 2010, 91:436-444.
6. Guo J, Jie W, Kuang D, Ni J, Chen D, Ao Q, et al. Ischaemia/reperfusion induced cardiac stem cell homing to the injured myocardium by stimulating stem cell factor expression via NF-kappaB pathway. Int J Exp Pathol 2009, 90:355-364.
7. Jie W, Wang X, Huang L, Guo J, Kuang D, Zhu P, et al. Contribution of CXCR4(+)/PDGFRbeta(+) progenitor cells in hypoxic alveolar arterioles muscularization: role of myocardin. Cardiovasc Res 2010, 87:740-750.
8. Jie W, Guo J, Shen Z, Wang X, Zheng S, Wang G, et al. Contribution of myocardin in the hypoxia-induced phenotypic switching of rat pulmonary arterial smooth muscle cells. Exp Mol Pathol 2010, 89:301-306.
9. Shen ZH, Chen XY, Chen J Impact of up-regulating Ezrin expression by Epstein-Barr virus latent membrane protein 1 on metastasis ability of nasopharyngeal carcinoma cells. Ai Zheng 2008, 27:165-169.
10. Cheung ST, Huang DP, Hui AB, Lo KW, Ko CW, Tsang YS, et al. Nasopharyngeal carcinoma cell line (C666-1) consistently harbouring Epstein-Barr virus. Int J Cancer 1999, 83:121-126.
11. Guo S, Mao X, Chen J, Huang B, Jin C, Xu Z, et al. Overexpression of Pim-1 in bladder cancer. J Exp Clin Cancer Res 2010, 29:161.
12. Xu D, Allsop SA, Witherspoon SM, Snider JL, Yeh JJ, Fiordalisi JJ, et al. The oncogenic kinase Pim-1 is modulated by K-Ras signaling and mediates transformed growth and radioresistance in human pancreatic ductal adenocarcinoma cells. Carcinogenesis 2011, 32:488-495.
13. Brault L, Gasser C, Bracher F, Huber K, Knapp S, Schwaller J PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers. Haematologica 2010, 95:1004-1015.
14. Holder S, Zemskova M, Zhang C, Tabrizizad M, Bremer R, Neidigh JW, et al. Characterization of a potent and selective small-molecule inhibitor of the PIM1 kinase. Mol Cancer Ther 2007, 6:163-172.
15. Willert M, Augstein A, Poitz DM, Schmeisser A, Strasser RH, Braun-Dullaeus RC Transcriptional regulation of Pim-1 kinase in vascular smooth muscle cells and its role for proliferation. Basic Res Cardiol 2010, 105:267-277.
16. Aho TL, Sandholm J, Peltola KJ, Mankonen HP, Lilly M, Koskinen PJ Pim-1 kinase promotes inactivation of the pro-apoptotic Bad protein by phosphorylating it on the Ser112 gatekeeper site. FEBS Lett 2004, 571:43-49.
17. Yan B, Zemskova M, Holder S, Chin V, Kraft A, Koskinen PJ, et al. The PIM-2 kinase phosphorylates BAD on serine 112 and reverses BAD-induced cell death. J Biol Chem 2003, 278:45358-45367.
18. Srosiri T, Sopee P, Boonyanit T Effect of lead on IL-8 production and cell proliferation in human oral keratinocytes. Asian Pac J Biomed 2010, 3(6):475-478.
19. Morishita D, Katayama R, Sekimizu K, Tsuruo T, Fujita N Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels. Cancer Res 2008, 68:5076-5085.
20. Mochizuki T, Kitanaka C, Noguchi K, Muramatsu T, Asai A, Kuchino Y Physical and functional interactions between Pim-1 kinase and Cdc25A phosphatase. Implications for the Pim-1-mediated activation of the c-Myc signaling pathway. J Biol Chem 1999, 274:18659-18666.
21. Leverson JD, Koskinen PJ, Orrico FC, Rainio EM, Jalkanen KJ, Dash AB, et al. Pim-1 kinase and p100 cooperate to enhance c-Myb activity. Mol Cell 1998, 2:417-425.
22. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 1996, 87:619-628.
23. Lilly M, Sandholm J, Cooper JJ, Koskinen PJ, Kraft A The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway. Oncogene 1999, 18:4022-4031.
24. Beharry Z, Zemskova M, Mahajan S, Zhang F, Ma J, Xia Z, et al. Novel benzylidene-thiazolidine-2,4-diones inhibit Pim protein kinase activity and induce cell cycle arrest in leukemia and prostate cancer cells. Mol Cancer Ther 2009, 8:1473-1483.
25. Lin YW, Beharry ZM, Hill EG, Song JH, Wang W, Xia Z, et al. A small molecule inhibitor of Pim protein kinases blocks the growth of precursor T-cell lymphoblastic leukemia/lymphoma. Blood 2010, 115:824-833.
26. Martin-Sanchez E, Sanchez-Beato M, Rodriguez ME, Sanchez-Espiridion B, Gomez-Abad C, Bischoff JR, et al. HDAC inhibitors induce cell cycle arrest, activate the apoptotic extrinsic pathway and synergize with a novel PIM inhibitor in Hodgkin lymphoma-derived cell lines. Br J Haematol 2011, 152:352-356.
27. Mumenthaler SM, Ng PY, Hodge A, Bearss D, Berk G, Kanekal S, et al. Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes. Mol Cancer Ther 2009, 8:2882-2893.
28. Li S, Xi Y, Zhang H, Wang Y, Wang X, Liu H, et al. A pivotal role for Pim-1 kinase in esophageal squamous cell carcinoma involving cell apoptosis induced by reducing Akt phosphorylation. Oncol Rep 2010, 24:997-1004.
29. Thomas M, Lange-Grunweller K, Weirauch U, Gutsch D, Aigner A, Grunweller A, et al. The proto-oncogene Pim-1 is a target of miR-33a. Oncogene 2011.
30. Zhang T, Zhang X, Ding K, Yang K, Zhang Z, Xu Y PIM-1 gene RNA interference induces growth inhibition and apoptosis of prostate cancer cells and suppresses tumor progression in vivo. J Surg Oncol 2010, 101:513-519.
31. Zheng H, Li LL, Hu DS, Deng XY, Cao Y Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma. Cell Mol Immunol 2007, 4:185-196.
32. Yoshizaki T Promotion of metastasis in nasopharyngeal carcinoma by Epstein-Barr virus latent membrane protein-1. Histol Histopathol 2002, 17:845-850.
33. Kim JH, Kim WS, Yun Y, Park C Epstein-Barr virus latent membrane protein 1 increases chemo-resistance of cancer cells via cytoplasmic sequestration of Pim-1. Cell Signal 2010, 22:1858-1863.
34. Chen Y, Chen XY Effect of Epstein-Barr virus latent membrane protein 1 (LMP1) on apoptosis of nasopharyngeal carcinoma cell line CNE1. Ai Zheng 2002, 21:498-503.